Literature DB >> 18048835

Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?

Michael S Ewer, Elizabeth Tan-Chiu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048835     DOI: 10.1200/JCO.2007.14.0657

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Trastuzamab (Herceptin)-related cardiotoxicity in pregnancy.

Authors:  Nicole J Roberts; Barry J Auld
Journal:  J R Soc Med       Date:  2010-04       Impact factor: 5.344

Review 2.  Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2010-10       Impact factor: 32.419

3.  Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.

Authors:  Xianglin L Du; Rui Xia; Keith Burau; Chih-Chin Liu
Journal:  Med Oncol       Date:  2010-10-22       Impact factor: 3.064

Review 4.  Cardiotoxicity profile of trastuzumab.

Authors:  Steven M Ewer; Michael S Ewer
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series.

Authors:  Icro Meattini; Sara Cecchini; Cristina Muntoni; Vieri Scotti; Carla De Luca Cardillo; Monica Mangoni; Pierluigi Bonomo; Jacopo Nori; Donato Casella; Roberta Simoncini; Lorenzo Orzalesi; Simonetta Bianchi; Lorenzo Livi
Journal:  Med Oncol       Date:  2014-02-18       Impact factor: 3.064

Review 6.  Cardiotoxicity of molecularly targeted agents.

Authors:  Nadia Hedhli; Kerry S Russell
Journal:  Curr Cardiol Rev       Date:  2011-11

Review 7.  Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer.

Authors:  Tanja Marinko; Jure Dolenc; Cvetka Bilban-Jakopin
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

8.  Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.

Authors:  Lu Cao; Gang Cai; Cai Chang; Zhao-Zhi Yang; Yan Feng; Xiao-Li Yu; Jin-Li Ma; Jiong Wu; Xiao-Mao Guo; Jia-Yi Chen
Journal:  Oncotarget       Date:  2016-01-05

9.  Early Cardiotoxicity after Adjuvant Concomitant Treatment with Radiotherapy and Trastuzumab in Patients with Breast Cancer.

Authors:  Tanja Marinko; Simona Borstnar; Rok Blagus; Jure Dolenc; Cvetka Bilban-Jakopin
Journal:  Radiol Oncol       Date:  2018-02-25       Impact factor: 4.214

10.  [Developments in modern oncology. Ramifications for anesthesia and intensive care medicine].

Authors:  B Alt-Epping; S Alt-Epping; M Quintel; F Nauck
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.